CLOROX (CLX) Director Receives 212.8954 DSUs; Total 18,799.5242

Spencer C. Fleischer, a director of Clorox Co. (CLX), reported two acquisitions of deferred stock units under the board’s deferred compensation plan.

Rhea-AI Filing Summary

Spencer C. Fleischer, a director of Clorox Co. (CLX), reported two acquisitions of deferred stock units under the board’s deferred compensation plan. On 08/29/2025 he received 192.9623 deferred stock units through dividend reinvestment and on 09/30/2025 he received 212.8954 units in lieu of quarterly director fees. The filing states the deferred stock units will be settled 1-for-1 in Clorox common stock upon the reporting person’s retirement or termination. Following the reported transactions, the filing shows total beneficial ownership of 18,799.5242 common shares.

Insider Trade Summary

Grant/Award: 405.8577 shares

Grant/Award 2 txns

Insider Fleischer Spencer C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	212.8954	$0.00	$0.00
Grant/Award	Deferred Stock Units	192.9623	$0.00	$0.00

Holdings After Transaction: Deferred Stock Units — 18,799.5242 contracts (Direct)

Footnotes (4)

1. F1. 1-for-1
2. F2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
3. F3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
4. F4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions did Spencer C. Fleischer report on the CLX Form 4?

He reported acquisition of 192.9623 deferred stock units on 08/29/2025 and 212.8954 units on 09/30/2025.

How will the deferred stock units be settled according to the filing?

The filing states the deferred stock units will be settled 100% in Clorox common stock upon the reporting person’s retirement or other termination of service.

What is Spencer C. Fleischer’s reported beneficial ownership after these transactions?

The Form 4 reports total beneficial ownership of 18,799.5242 common shares following the reported transactions.

Why were the deferred stock units granted on 08/29/2025 and 09/30/2025?

The filing explains the 08/29/2025 units were from dividend reinvestment and the 09/30/2025 units were received in lieu of quarterly director fees.

Who signed the Form 4 filing and when?

The Form 4 was signed by Jinho Joo, Attorney-in-Fact on 10/02/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/02/2025 - 04:17 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Fleischer Spencer C

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	08/29/2025		A(2)	V	192.9623		(3)	(3)	Common Stock	192.9623	$0.0000	18,586.6288	D
Deferred Stock Units	(1)	09/30/2025		A(4)		212.8954		(3)	(3)	Common Stock	212.8954	$0.0000	18,799.5242	D

Explanation of Responses:

1. 1-for-1

2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

	By Jinho Joo, Attorney-in-Fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.